Metoprolol Tartrate And Hydrochlorothiazide NDC 27241-301

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-301Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0301Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-301-01	27241030101	100 TABLET in 1 BOTTLE (27241-301-01)Marketed from Mar 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoprolol Tartrate And Hydrochlorothiazide
Generic name (nonproprietary): metoprolol tartrate and hydrochlorothiazide
Active ingredients: Metoprolol tartrate — 50 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215789
Marketing start: Mar 15, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 27241-301_c1d86752-98ac-48af-8023-e57b40270660SPL ID c1d86752-98ac-48af-8023-e57b40270660SPL set ID 8b78d7ad-22a8-4a9f-afb5-d18f0a4e6d36RxCUI 866479, 866482UNII W5S57Y3A5L, 0J48LPH2TH
Pharmacologic class: Thiazide Diuretic; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241030101 followed by a unit qualifier and the quantity

Package 27241-0301-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2025.

Indications (excerpt from the label)

Metoprolol tartrate and hydrochlorothiazide tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215789

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215789
Product	Strength	Form · route	Labeler	Product NDC
Metoprolol Tartrate And Hydrochlorothiazide	Metoprolol tartrate 100 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-302